GB0106446D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0106446D0
GB0106446D0 GBGB0106446.8A GB0106446A GB0106446D0 GB 0106446 D0 GB0106446 D0 GB 0106446D0 GB 0106446 A GB0106446 A GB 0106446A GB 0106446 D0 GB0106446 D0 GB 0106446D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0106446.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis Research Ltd
Original Assignee
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd
Priority to GBGB0106446.8A priority Critical patent/GB0106446D0/en
Publication of GB0106446D0 publication Critical patent/GB0106446D0/en
Priority to PCT/GB2002/001220 priority patent/WO2002074288A2/en
Priority to AU2002246228A priority patent/AU2002246228A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
GBGB0106446.8A 2001-03-15 2001-03-15 Chemical compounds Ceased GB0106446D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0106446.8A GB0106446D0 (en) 2001-03-15 2001-03-15 Chemical compounds
PCT/GB2002/001220 WO2002074288A2 (en) 2001-03-15 2002-03-15 Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide
AU2002246228A AU2002246228A1 (en) 2001-03-15 2002-03-15 Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0106446.8A GB0106446D0 (en) 2001-03-15 2001-03-15 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0106446D0 true GB0106446D0 (en) 2001-05-02

Family

ID=9910774

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0106446.8A Ceased GB0106446D0 (en) 2001-03-15 2001-03-15 Chemical compounds

Country Status (3)

Country Link
AU (1) AU2002246228A1 (en)
GB (1) GB0106446D0 (en)
WO (1) WO2002074288A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
MXPA06000623A (en) * 2003-07-16 2006-04-11 Pfizer Treatment of sexual dysfunction.
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
JP2009503020A (en) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of flibanserin in the treatment of obesity
JP2009541443A (en) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Flibanserin for the treatment of urinary incontinence and related diseases
PE20091188A1 (en) 2007-09-12 2009-08-31 Boehringer Ingelheim Int COMPOUND 1- [2- (4- (3-TRIFLUOROMETIL-PHENYL) PIPERAZIN-1-IL) ETHYL] -2,3-DIHYDRO-1H-BENZIMIDAZOL-2-ONA (FLIBANSERIN), ITS ADDITION SALTS AND PHARMACEUTICAL COMPOSITIONS THAT THEY CONTAIN
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109872A (en) * 1993-06-10 2000-12-06 Lilly Co Eli Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
WO2002074288A2 (en) 2002-09-26
WO2002074288A3 (en) 2003-02-27
AU2002246228A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
GB0115109D0 (en) Chemical compounds
GB0103926D0 (en) Chemical compounds
GB0103630D0 (en) Chemical compounds
GB0115393D0 (en) Chemical compounds
GB0124931D0 (en) Chemical compounds
GB0114005D0 (en) Chemical compounds
GB0108046D0 (en) Chemical compounds
AU2002366440A8 (en) Chemical compounds
GB0108793D0 (en) Chemical compounds
GB0108764D0 (en) Chemical compounds
GB0113231D0 (en) Chemical compounds
GB0106446D0 (en) Chemical compounds
GB0110797D0 (en) Chemical compounds
GB0101226D0 (en) Chemical compounds
GB0108594D0 (en) Chemical compounds
GB0114370D0 (en) Chemical compounds
GB0106877D0 (en) Chemical compounds
GB0105077D0 (en) Chemical Compounds
GB0115545D0 (en) Chemical compounds
GB0115544D0 (en) Chemical compounds
GB0104418D0 (en) Chemical compounds
GB0115392D0 (en) Chemical compounds
GB0103990D0 (en) Chemical compounds
GB0108593D0 (en) Chemical compounds
GB0114349D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)